Compare NCI Cancer Hospital vs Progenix Research
Customers evaluate the quality of NCI Cancer Hospital's products using the following success metrics.
Overview
NCI Cancer Hospital is based in Malaysia
NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.
Progenix Research is based in United Kingdom
Progenix Research is an independent contract research organisation offering toxicology services to the world-wide pharmaceutical, biotechnology, agrochemical and industrial chemical industries. It is a newly formed, independent contract research organisation with laboratory facilities currently under construction in Penang, Malaysia. The company's European headquarters are based in Malvern, England, and it also has a histopathology laboratory in Edinburgh, Scotland. A high quality, yet cost-efficient service for toxicology and associated studies will be offered, including studies on pharmaceuticals, biotechnology products, medical devices, food additives, agrochemicals, biocides, and speciality chemicals.
Demo Video
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because NCI Cancer Hospital has not claimed their profile.
Work for NCI Cancer Hospital? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for NCI Cancer Hospital?
Claim your profile now.
Information not available because Progenix Research has not claimed their profile.
Work for Progenix Research? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Progenix Research?
Claim your profile now.